Skip to content

Wen-Sheng Huang

4 papers in the library · 32 citations · publishing 2016-2024

Papers

Sort Most recent Most cited

Dextromethorphan moderates reward deficiency associated with central serotonin transporter availability in 3,4-methylenedioxy-methamphetamine-treated animals.

Journal of the Chinese Medical Association : JCMA May 1, 2024 Chuang-Hsin Chiu, Kuo-Hsing Ma, Eagle Yi-Kung Huang et al. 4 citations

The neurotoxicity of 3,4-methylenedioxy-methamphetamine (MDMA) to the serotonergic system is well-documented. Dextromethorphan (DM), an antitussive drug, decreased morphine- or methamphetamine (MA)-induced reward in rats and may prevent MDMA-induced serotonergic deficiency in primates, as indicated by increased serotonin transporter (SERT) availability. We aimed to investigate the effects of DM...

DOI: 10.1097/JCMA.0000000000001087 (opens in new tab) Full text (opens in new tab) Addiction research Drug interactions Harm reduction Brain chemistry

Amitriptyline Accelerates SERT Binding Recovery in a Rat 3,4-Methylenedioxymethamphetamine (MDMA) Model: In Vivo 4-[18F]-ADAM PET Imaging

International Journal of Molecular Sciences June 24, 2022 Chi-Jung Tsai, Chuang-Hsin Chiu, Yu-Yeh Kuo et al.

Numerous studies have confirmed that 3,4-Methylenedioxymethamphetamine (MDMA) produces long-lasting changes to the density of the serotonin reuptake transporter (SERT). Amitriptyline (AMI) has been shown to exert neuroprotective properties in neuropathologic injury. Here, we used a SERT-specific radionuclide, 4-[18F]-ADAM, to assess the longitudinal alterations in SERT binding and evaluate the...

Functional Dysconnectivity of Frontal Cortex to Striatum Predicts Ketamine Infusion Response in Treatment-Resistant Depression.

The International Journal of Neuropsychopharmacology December 29, 2020 Mu-Hong Chen, Wan-Chen Chang, Wei-Chen Lin et al. 28 citations

Frontostriatal disconnectivity plays a crucial role in the pathophysiology of major depressive disorder. However, whether the baseline functional connectivity of the frontostriatal network could predict the treatment outcome of low-dose ketamine infusion remains unknown. In total, 48 patients with treatment-resistant depression were randomly divided into 3 treatment groups (a single-dose...

DOI: 10.1093/ijnp/pyaa056 (opens in new tab) Full text (opens in new tab) Treatment-resistant depression Frontostriatal network Low-dose ketamine infusion Treatment response

Effects of dextromethorphan on MDMA-induced serotonergic aberration in the brains of non-human primates using [123I]-ADAM/SPECT.

Scientific Reports December 12, 2016 Kuo-Hsing Ma, Tsung-Ta Liu, Shao-Ju Weng et al.

3,4-Methylenedioxymethamphetamine (MDMA), a common recreational drug, is known to cause serotonergic neurotoxicity in the brain. Dextromethorphan (DM) is a widely used antitussive reported to exert anti-inflammatory effect in vivo. In this study, we examined the long-term effect of MDMA on the primate serotonergic system and the protective property of DM against MDMA-induced serotonergic...